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Purpose: To determine the knowledge, attitude and practice of ADR monitoring and reporting among 
healthcare workers in a teaching hospital in Kano, Nigeria 
Methods: The study was cross-sectional and questionnaire-based involving mainly medical doctors, 
nurses and pharmacists working in different departments of the Aminu Kano Teaching Hospital hospital. 
A total of 110 questionnaires were distributed to the respondents (60 doctors, 40 nurses, 10 
pharmacists). The completion of the questionnaire by respondents was taken as their consent to 
participate in the study. 
Results: Only 65 respondents filled and returned the questionnaire within the stipulated time frame 
giving a response rate of about 59.1 %. The standard yellow reporting form for adverse drug reactions 
was only known to 35.9 % of the participating health care workers. Only 42.7 % of the respondents had 
ever reported an adverse drug reaction and the report was verbal in over 75 % of cases. Ignorance of 
the rules and procedures of reporting, lack  of knowledge of the forms for reporting and which ADRs to 
report were some of the factors responsible for non-reporting of adverse drug reactions among 
respondents in the study 
Conclusion: Adverse drug reaction reporting using the yellow card reporting scheme is low among 
health care workers (doctors, nurses and pharmacists) in Kano, Nigeria. There is a need for regular 
training and re-enforcement of guidelines for ADR reporting among health care personnel. The inclusion 
of nurses in pharmacovigilance will go a long way in improving reporting of ADRs. 
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INTRODUCTION 
 
Adverse drug reactions (ADRs) are an 
important cause of morbidity and mortality 
worldwide [1].  According to World Health 
Organization (WHO) definition, an ADR is 
any noxious, unintended, and undesired 
effect of a drug, which occurs at doses used 
in humans for prophylaxis, diagnosis, or 
therapy [2]. The socio-economic and health 
consequences of ADRs have been 
highlighted in several studies [1,3,4]. While a 
majority of the studies cited above show 
prevalence of this problem in developed 
countries, there is paucity of accurate data 
from many developing countries.  
 
Out of the several methods of detecting 
ADRs, spontaneous reporting is one that has 
contributed significantly to improved levels of 
pharmacovigilance in many countries [5,6]. 
The importance of healthcare workers in the 
area of spontaneous reporting of ADRs and 
development of ADR databases worldwide 
has been established in previous studies 
[7,8]. Previous studies from different regions 
in Nigeria have concentrated on the 
perception and practice of ADRs reporting 
among physicians only while excluding other 
cadres of healthcare workers [9-11]. It is 
clear, however, that nurses and pharmacists 
have very important roles to play in ADR 
monitoring and reporting [12,13].  Despite the 
better ADR reporting culture of the developed 
nations, under-reporting is a major issue with 
spontaneous reporting [14,15]. The predictors 
of under-reporting have been described 
severally by many workers [16-18] but these 
differ from study to study.  
 
The objective of this study was to determine 
the knowledge, attitude and practice of ADR 
monitoring and reporting among healthcare 
workers (medical doctors, nurses and 








This study was conducted at Aminu Kano 
Teaching Hospital, Kano in northwestern part 
of Nigeria during the month of April 2008. It is 
one of the major tertiary health facilities in the 
area, providing medical and other ancillary 
services to about 10 million people, and also 
provides postgraduate training to resident 
doctors. It has four major clinical units, 
namely, Internal Medicine, Surgery, 




The study was a cross-sectional 
questionnaire-based study involving medical 
doctors, nurses and pharmacists working in 
different departments of the hospital. A 
convenience sampling method through which 
the questionnaires were distributed to the 
participants during their departmental 
activities was applied for the study. The 
sampling frame consisted of one hundred 
and sixty doctors (80 residents, 60 interns 
and 20 consultants) from the four clinical 
specialties, eighty nurses and twenty 
pharmacists servicing the needs of the 
teaching hospital.  A sample size of one 
hundred and ten was considered 
proportionate and representative of this 
sampling frame. The questionnaire was 
adapted from a similar study investigating the 
attitudes and practice of ADR reporting 
among physicians in Nigeria [9]. It was 
designed to capture the following information: 
bio-data of respondents, professional group 
(medical doctors, pharmacists, and nurses), 
duration of practice, level of practice (e.g., 
interns, registrar), information about the 
knowledge and practice of ADR reporting, 
factors that may likely affect their reporting of 





A total of 110 questionnaires were distributed 
to medical doctors (60) through chief 
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residents of clinical departments; to nurses 
(40) through the Chief Nursing Officers of the 
respective wards and to pharmacists through 
the Assistant Chief Pharmacist. A time frame 
of one week was allowed for the collection of 
the anonymously filled forms. The completion 
of the questionnaire by respondents was 
taken as their consent to participate in the 
study. All cadres of medical doctors 
(consultants inclusive) had the questionnaires 
distributed to them and there was no 
deliberate plan to exclude any particular 
class.  The absence of any cadre of doctors 
in the analysis could be due to their not 





Information from the returned questionnaire 
was coded and entered into SPSS version 12 
software. The results are presented as mean 
± standard deviation, counts and 
percentages.  The relationship between the 
different professional classes, duration of 
practice and their knowledge and practice of 
ADR reporting were determined using Chi-




Only sixty-five respondents filled and 
returned their questionnaire within the 
stipulated time frame giving a response rate 
of about fifty-nine percent (59.1%). The 
demographics of the respondents, distribution 
by professional cadre and experience are 
shown in Table 1.  
 
Table 1: Demographics of respondents 
 
Characteristics Values 
Mean age  (yr) 32.97 ± 6.1 (range 24-49) 
Professional 
experience (yr) 
7.32 ± 7.43 (range 0.5 -25) 
Male : female 46:19 
Professional 
groups 
Medical doctors: 43 (66.2%) 
Nurses: 20 (30.8%) 
Pharmacists: 2 (3.1%) 
Level of practice 
(Medical doctors 
only) 
House Physicians: 25 (59.5%) 
Registrars: 13 (31%) 
Senior Registrar: 4 (9.5%) 
Missing: 23 
 
Table 2 shows that a majority of the 
respondents (93.8 %) agreed that adverse 
drug reactions are an important cause of 
morbidity and mortality in medical practice. 
Regarding laws guiding the reporting of 
adverse drug reactions, eighteen of the 
medical doctors (42.9 %) and seven nurses 
(35%) were aware of their existence. The 
standard yellow reporting form for adverse 
drug reactions was only known to 39.5%, 
26.3% and 50% of the participating doctors, 
nurses and pharmacists respectively. 
 
Table 2: Healthcare workers’ knowledge of ADR reporting and monitoring by professional class 
 
Question Medical Doctors Nurses Pharmacists Stat. significance 
Have you ever seen 
the Yellow Form 
YES – 17 (39.5%) 
NO – 26 (60.5%) 
YES – 5 (26.3%) 
NO – 14 (73.7%) 
YES – 1 (50%) 
NO – 1 (50%) 
None 
Awareness of laws 
guiding ADRs reporting 
YES – 18 (42.9%) 
NO – 24 (57.1%) 
YES – 7 (35%) 
NO – 13 (65%) 
YES – 1 (50%) 
NO – 1 (50%) 
None 
Have you ever 
observed a suspected 
ADR 
YES – 36 (85.7%) 
NO – 6 (14.3%) 
YES – 14 (73.7%) 
NO – 5 (26.3%) 
YES – 1 (50%) 
NO – 1 (50%) 
None 
Have you ever 
reported a suspected 
ADR 
YES – 12 (30.8%) 
NO – 27 (69.2%) 
YES – 12 (75%) 
NO – 4 (25%) 
YES –  
NO – 1(50%) 
Yes (p = 0.007) 
Do you obtain regular 
information on ADRs 
YES – 10 (23.8%) 
NO – 32 (76.2%) 
YES – 7 (38.9%) 
NO – 11 (61.1%) 
YES – 2 (100%) None 
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It is interesting to note that while over eighty-
one percent of the respondents had observed 
at least an episode of adverse drug reaction, 
less than half (42.7 %) of them had ever 
reported it. The main method of reporting 
found in this study was verbal  and the report 
was made to a member of the managing 
medical team in over seventy-five percent of 
cases. The result also showed that a larger 
proportion (75%) of the nurses had reported 
at least a case of ADR as opposed to the 
medical doctors (30.8%) and that almost all 
the nurses put their report in the nurses 
report book. Table 3 shows the sources of 
ADR information used by the respondents. 
 
Table 3:  Sources of ADR information used by the 
respondents 
 
Source of ADR 
information 
Frequency 
Ministry of Health Drug 
Information Bulletin 
1 (2.2%) 
Drug information sheets 
(in drug packs) 
26 (56.5%) 
Text on drugs and 
therapies 
11 (23.9%) 
Scientific journals 1 (2.2%) 
Medical representatives 




Less than half of the respondents (44.6 %) 
were aware of the hospital’ pharmaco-
vigilance committee. Regarding the kind of 
reaction to be reported, a majority (> 70 %) of 
the respondents were aware that suspected, 
serious and certain reactions should be 
reported. Other types of reactions that should 
be reported according to the respondents 
are: reactions to new drugs, those mentioned 
in literature, unusual/unexpected reactions, 
possible interaction with other drugs and 
teratogenic reactions (see Table 4).  
 
The respondents identified the following 
factors as contributing to their non-reporting 
of ADRs: ignorance of the rules and 
procedures of reporting (66.1 %), lack of 
knowledge of the forms for reporting (74.1 %) 
and of what constituted ADRs (48.3 %). 
These and other factors contributing to non-
reporting are shown in Table 5. 
 
Table 4: Knowledge of respondents on 
reactions to be reported 
 
Response Reporting of 
ADR’s/Professional 
group 
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Table 5: Factors contributing to non-reporting of 
ADRs 
 
Response Reporting of 
ADR’s/Professio
nal group 
Yes No Don’t 
know 
None 
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The study also showed that the type of 
practice (medical or nursing) did have 
statistically significant effect on the reporting 




The fact that majority of respondents agreed 
that ADRs are an important problem in 
medical practice is an encouraging finding 
from our study. Our earlier reported finding of 
lack of knowledge of the yellow reporting 
forms by majority of the respondents is in line 
with similar studies in Nigeria [9-11]. The 
reason for the similarities among different 
geographical regions of Nigeria could be due 
to inadequate attention to the subject of 
ADRs in the clinical pharmacology and 
therapeutics curricula of medical schools. 
This common observation about lack of 
knowledge about the yellow forms could also 
indicate that under-reporting of ADRs is a 
major issue in Nigeria with its attendant 
consequences. Some studies in the USA and 
France [2,3] had shown that ADRs contribute 
significantly to morbidity and mortality in 
clinical practice with its associated economic 
consequences. It seems that the situation in 
Nigeria may not be very different and the 
problem is unrecognized due to gross under-
reporting.  
 
Under-reporting of ADRs is a worldwide 
phenomenon and this has been established 
from previous studies [14,15,19,20]. The 
determinants of under-reporting, from our 
study, include lack of knowledge of the forms 
for reporting, ignorance of the rules and 
procedure for reporting, and not being sure of 
the type of reactions to be reported. This 
tallies, to a large extent, with other reports 
from Nigeria, China and Malaysia [9,18,21]. 
While it is important to note that these studies 
were carried out among physicians, several 
other studies involving pharmacists have 
indeed confirmed that under-reporting of 
ADRs is common to all health care 
professionals [22,23]. It is also interesting to 
note the non-response of medical consultants 
and the low level of participation by 
pharmacists in this study. This outcome could 
be a reflection of the importance attached to 
the problem of ADRs by this category of 
medical personnel and this is not very 
encouraging. A similar study carried out in 
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Ibadan [9] also included only residents; this 
raises questions about the accessibility of 
medical consultants for such important 
studies.  
 
Our study included some nurses because of 
their primary importance in the care of 
patients, especially patients on hospital 
admission. Because nurses are in the ward at 
all times, it is most likely that any acute 
adverse drug reaction will first be observed 
by them, hence it is important that they 
participate in the spontaneous reporting 
scheme. In countries where nurses are 
already participating in the ADR reporting 
scheme, studies have shown that they indeed 
contribute positively towards the promotion of 
ADR reporting [7,24]. In this study, a majority 
of the nurses reported some form of ADR 
through the nurses daily report book and not 
the yellow card reporting scheme. This 
finding highlights the important role nurses 
can play if they are properly trained in the 
area of pharmacovigilance. 
 
It is a known fact that information regarding 
ADRs changes on a daily basis and hence 
the need for constant updating of the 
knowledge of health care professionals in this 
area.  Most respondents in this study 
obtained their information on ADRs from drug 
information sheets and texts on drugs. Lack 
of, or inadequate, access to the internet can 
be a major limiting factor (where internet 
facilities are poor) for obtaining current 
reports on ADRs as most information from 
drug inserts and textbooks on drugs may be 
outdated and may not reflect the current state 
of information on ADRs. 
 
In order to address some of the determinants 
of under-reporting found in this study, ADR 
reporting guidelines should be made 
available in the form of booklets and posters 
at conspicuous locations in health care 
facilities to serve as a constant reminder. 
This should be in addition to regular 
sensitization of all health care workers on the 
importance of pharmacovigilance in the quest 
to decrease morbidity and mortality among 
the populace. Some workers have suggested 
the use of financial incentives as a tool to 
stimulate reporting of ADRs [25]. Apart from 
the fact that the use of incentives have not 
been widely accepted and practiced, it raises 
the possibility of over-reporting by some 
health care workers in a bid to obtain 
financial rewards. This should not be 
supported because ADR reporting should be 
a fundamental responsibility of health care 
workers and, therefore, it should be 
understood as such.  
 
Improving ADR reporting, apart from reducing 
the incidence of adverse drug reactions in 
clinical practice, will also lead to a reduction 
in health care costs. Another way to increase 
the reporting of ADRs is through the 
promotion of patient self-reporting. The 
benefits of this idea have been confirmed in 
different studies [26,27]. Patient self-reporting 
has a complimentary role to play in 
increasing the level of ADR reporting in a 
developing country such as Nigeria. Although 
Nigeria’s regulatory agency, National Agency 
for Food and Drug Administration Control 
(NAFDAC), has been doing a lot of 
sensitization through the media regarding the 
issue of ADR reporting, efforts should also be 
made to make the reporting process by 
patients simple and straightforward.  
The lack of awareness of the availability of 
pharmacovigilance committee in the Aminu 
Kano Teaching Hospital, Kano by more than 
half of the respondents indicates the need to 
extend the level of sensitization for health 
care workers to improve their ADR reporting.  
 
Limitations of the study 
 
The main limitation of our study was the 
relatively small number of respondents, 
especially pharmacists. In addition, some 
other factors that are associated with self-
reporting studies such as accuracy of recall, 
personal bias and could also have affected, 
in some ways, the results of this study. The 
opinion of non-responders in general and 
participants who did not respond to certain 
Fadare et al  
Trop J Pharm Res, June 2011;10 (3): 241 
aspects of the questionnaire could also have 




Adverse drug reaction reporting using the 
Yellow Card reporting scheme is low among 
health care workers (doctors, nurses and 
pharmacists) at the Aminu Kano Teaching 
Hospital, Kano, Nigeria. There is a need for 
regular training and re-enforcement of 
guidelines for ADR reporting among health 
care personnel. Yellow card ADR reporting 
by nurses and patient self-reporting should 
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